Sentence examples for trial very well from inspiring English sources

After being put to work in the ship's coal bunkers, according to Wild, Marr "came out of the trial very well, showing an amount of hardihood and endurance that was remarkable".

Altogether, 10 of 19 of the children and adolescents were able to understand the information about the trial very well, 7 of 19 understood the information at a large extent but showed some deficiencies in understanding and only 2 of 19 children had a completely insufficient understanding.

The PGIR approach evaluated within this trial faired very well in one small monocentre trial with a small sample size [ 17] but has never been evaluated within a multicentre trial.

An efficacy endpoint in such a trial could very well be the duration of the aura, since many patients suffering from migraine with aura are severely disabled by the aura itself.

Perhaps most importantly, the trial was very well received by participants, with primary care thought to be a highly appropriate setting for such an intervention.

Furthermore, the findings of this trial correlate very well with the results of a recently published preclinical study, which found that LEV did not only lack a significant growth inhibitory effect as a single agent in colon cancer cell lines, but also antagonised 5-FU-induced tumour growth inhibition when combined with this cytostatic agent (Wiebke et al, 2003).

Thus, despite the experiences of the participants in this study and benefits they may have received as individuals by accessing CCSVI treatment abroad, the decision within Canada not to provide access to CCSVI treatment outside of clinical trials is very well supported on grounds of patient safety and the efficient distribution of health resources.

When asked by local reporters if he was feeling any pressure related to the case, Judge Shams said: "The trial is going very well, it is transparent.

"Our Portland trial is going very well for us," said Eric Rosenblum, director for Google Offers.

As already demonstrated in the large phase II trial, NEPA was very well tolerated with a comparable adverse event profile to PALO.

This, especially in the context where a substantial number of respondents set very aggressive lipid goals that are in line with recent trial data, could very well indicate a need for more frequent revisions of clinical practice guidelines as new data emerges.